Aoun, Fouad <br/><br/>
Checkpoint inhibitors in bladder and renal cancers: results and perspectives.  [electronic resource] 

 -  Immunotherapy  2015 
 - 1259-71 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1750-7448 
<br/><br/><label>Standard No.: </label>10.2217/imt.15.91  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--adverse effects<br/>B7-H1 Antigen--antagonists & inhibitors<br/>CTLA-4 Antigen--antagonists & inhibitors<br/>Carcinoma, Renal Cell--drug therapy<br/>Cell Cycle Checkpoints--immunology<br/>Drug Resistance, Neoplasm<br/>Humans<br/>Immunotherapy--adverse effects<br/>Kidney Neoplasms--drug therapy<br/>Molecular Targeted Therapy--adverse effects<br/>Programmed Cell Death 1 Receptor--antagonists & inhibitors<br/>T-Lymphocytes, Cytotoxic--immunology<br/>Urinary Bladder Neoplasms--drug therapy